Cargando…

Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report

INTRODUCTION: Osteonecrosis (ON) is characterized by cellular death of bone components due to interruption of blood supply that leads to bone ischemia and potential joint destruction. There are multiple risk factors and medical condition associated with ON, including systemic lupus erythematosus (SL...

Descripción completa

Detalles Bibliográficos
Autores principales: Oesman, Ihsan, Adhimukti, Danarto Hari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649589/
https://www.ncbi.nlm.nih.gov/pubmed/33160171
http://dx.doi.org/10.1016/j.ijscr.2020.10.069
_version_ 1783607354811482112
author Oesman, Ihsan
Adhimukti, Danarto Hari
author_facet Oesman, Ihsan
Adhimukti, Danarto Hari
author_sort Oesman, Ihsan
collection PubMed
description INTRODUCTION: Osteonecrosis (ON) is characterized by cellular death of bone components due to interruption of blood supply that leads to bone ischemia and potential joint destruction. There are multiple risk factors and medical condition associated with ON, including systemic lupus erythematosus (SLE). The most common sites of ON are the femoral head, distal femur, proximal humerus, talus and lumbar spine. Very few cases of nontraumatic ON in distal tibia have been reported in the literature. CASE ILLUSTRATION: We present a case of 23-year-old female diagnosed with osteonecrosis of distal tibia and history of SLE. The patient also had history of avascular necrosis of right hip and underwent right total hip arthroplasty. We treated the patients with conservative treatment for intial management. DISCUSSION: The risk of ON in SLE patients is likely due to the results of both the SLE itself and use of corticosteroids. Systemic inflammation in SLE reduces the development of osteoblasts, increases osteoclast maturation and activity and increases protohrombotic agents that can lead to rapid bone loss. Corticosteroids are the most consistent risk factor associated with the development of ON in SLE. Conservative medical management is effective in the early stages of the disease before bone collapse. CONCLUSION: Despite advances in the diagnosis and treatment of SLE, symptomatic ON continues to be a significant comorbidity. Strategies to detect and manage early stage ON is necessary to prevent the progression of this serious complication.
format Online
Article
Text
id pubmed-7649589
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76495892020-11-16 Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report Oesman, Ihsan Adhimukti, Danarto Hari Int J Surg Case Rep Case Report INTRODUCTION: Osteonecrosis (ON) is characterized by cellular death of bone components due to interruption of blood supply that leads to bone ischemia and potential joint destruction. There are multiple risk factors and medical condition associated with ON, including systemic lupus erythematosus (SLE). The most common sites of ON are the femoral head, distal femur, proximal humerus, talus and lumbar spine. Very few cases of nontraumatic ON in distal tibia have been reported in the literature. CASE ILLUSTRATION: We present a case of 23-year-old female diagnosed with osteonecrosis of distal tibia and history of SLE. The patient also had history of avascular necrosis of right hip and underwent right total hip arthroplasty. We treated the patients with conservative treatment for intial management. DISCUSSION: The risk of ON in SLE patients is likely due to the results of both the SLE itself and use of corticosteroids. Systemic inflammation in SLE reduces the development of osteoblasts, increases osteoclast maturation and activity and increases protohrombotic agents that can lead to rapid bone loss. Corticosteroids are the most consistent risk factor associated with the development of ON in SLE. Conservative medical management is effective in the early stages of the disease before bone collapse. CONCLUSION: Despite advances in the diagnosis and treatment of SLE, symptomatic ON continues to be a significant comorbidity. Strategies to detect and manage early stage ON is necessary to prevent the progression of this serious complication. Elsevier 2020-10-28 /pmc/articles/PMC7649589/ /pubmed/33160171 http://dx.doi.org/10.1016/j.ijscr.2020.10.069 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Oesman, Ihsan
Adhimukti, Danarto Hari
Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title_full Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title_fullStr Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title_full_unstemmed Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title_short Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report
title_sort osteonecrosis of the distal tibia in systemic lupus erythematosus: a rare case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649589/
https://www.ncbi.nlm.nih.gov/pubmed/33160171
http://dx.doi.org/10.1016/j.ijscr.2020.10.069
work_keys_str_mv AT oesmanihsan osteonecrosisofthedistaltibiainsystemiclupuserythematosusararecasereport
AT adhimuktidanartohari osteonecrosisofthedistaltibiainsystemiclupuserythematosusararecasereport